SecBot SecBot

ASBPW

Aspire-Lakewood Holdings, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. E9· CIK 0001847345 Biotech & Drug Discovery
Warrants of Aspire-Lakewood Holdings, Inc. · ASBP stock page →
—
Market cap
$21.5K
Nano cap
1 year
−52.6%
from $17.80 · Oct 28
30 days
−0.7%
from $8.50
52-week range
$0.1550–17.80
−53% from high · low May 7
Avg volume 20D
30.6K
Oct 14 spike 87.1K
Short interest
4.9K
≈0.3% of shares · 0.0%
Days to cover
187.5
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read BULLISH 5 reports · latest
Balance 1 bearish · 3 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest BULLISH Aspire Biopharma closed the second tranche of a $21 million private placement and secured a $22.5 million…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest 0.0% to 4.9K shares. 187.5 days to cover, ≈0.3% of shares.

  • TrendRANGE

    1% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BARCLAYS PLCNEAR_EXIT291$6.00
Verition Fund Management LLCTRIM191,021$3.2K
Sculptor Capital LPNEAR_EXIT500,000$22.5K

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
4,876
shares short
0.0%
vs prior settlement
187.5
days to cover
≈0.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2026 Inst.
BARCLAYS PLC — NEAR_EXIT
291 shares ($6.00)
Apr 20, 2026 SEC
Aspire Biopharma closed the second tranche of a $21 million private placement and secured a $22.5 million commitment…
8-K — Impact 7/10
Apr 16, 2026 SEC
Aspire Biopharma Holdings, Inc. completed a second closing of its private placement, issuing an additional 12,500…
8-K — Impact 6/10
Apr 16, 2026 SEC
Aspire Biopharma announced a letter of intent to acquire Dura Driver Control Systems, a profitable automotive supplier…
8-K — Impact 7/10
Mar 31, 2026 Inst.
Verition Fund Management LLC — TRIM
191,021 shares ($3.2K)

SecBot reports

5 filings · 3 bullish · 1 bearish · 1 neutral
All ASBPW filing & press-release reports (5)